Aug 2026· Frontiers in Genetics· Vol 17· 0 citations· 24 references
Medicine
TL;DR
A pathogenic splicing variant in PKD1 is validated and successfully applied PGT-M to prevent disease transmission, resulting in an unaffected pregnancy and subsequent prenatal diagnosis confirmed the absence of the variant and a normal chromosomal karyotype.
Abstract
Background Autosomal dominant polycystic kidney disease (ADPKD) is most commonly caused by pathogenic variants in PKD1. Here, we reported the functional characterization of an intronic PKD1 variant identified in an ADPKD-affected family and its subsequent application in preimplantation genetic testing for monogenic disorders (PGT-M). Case presentation A three-generation ADPKD family was enrolled. Whole-exome sequencing revealed a heterozygous PKD1 c.7489 + 5G>A variant, which co-segregated with the disease and was initially classified as a variant of uncertain significance. A minigene assay demonstrated that the variant induced skipping of exon 18, leading to a frameshift (p.Arg2404Valfs*123), supporting its reclassification as pathogenic. The couple underwent PGT-M using trophectoderm biopsy, haplotype linkage analysis, and direct mutation detection. An unaffected pregnancy was achieved, and subsequent prenatal diagnosis confirmed the absence of the variant and a normal chromosomal karyotype. Conclusion We validated a pathogenic splicing variant in PKD1 and successfully applied PGT-M to prevent disease transmission, resulting in an unaffected pregnancy.
The findings identify structural PKD2 variation as an under-recognized cause of genetically unresolved late-onset ADPKD and demonstrate that phenotype-guided incorporation of copy number analysis can overcome limitations of NGS alone.
Akrivi Papachristopoulou, Angeliki Margoni, A. Simoudis et al.· Medicina· 0 citations
A Chinese patient presenting with classic hallmarks of MGORS7 alongside atypical clinical features, including hearing and visual impairments is reported, suggesting that growth hormone therapy may be beneficial for growth retardation in patients with MGORS7.
Ying Zhao, Yi-Yang Fu, Shu-Ying Zhang et al.· Frontiers in Genetics· 0 citations
The utility of segregation studies for classifying genetic variants, as applied to a family with severe ADPKD and a novel PKD1 missense variant, is demonstrated, demonstrating the value of segregation studies and accurate clinical phenotyping in genetic variant annotation.
A. Vasconcelos, Liliana Rocha, Susana Fernandes et al.· American Journal of Medical...· 0 citations
This case demonstrates that genetic testing can guide personalized management in young patients with FSGS, offering a practical framework for avoiding unnecessary treatment-related morbidity and highlights the value of early supportive therapy in genetic FSGS.
Fan Yang, Xiao-Qi Wang, Yan Li et al.· Frontiers in Genetics· 0 citations
It is demonstrated that even in the absence of functional experiments, comprehensive family analysis can provide crucial clues for variant of uncertain significance (VUS) interpretation.
Xiu-Lan Hao, Yan-Chou Ye, Man Liu et al.· Frontiers in Genetics· 0 citations
This case indicates that PGT-M is a viable option for NPHP3-related MKS and BRCA-positive patients to avoid transmission while maintaining their families, and successful application of PGT-M provides a potential approach for treating other monogenic diseases.
Yi-Yuan Zhang, Xian-Jing Huang, Ping-Ping Qiu et al.· Genetics and Molecular Biolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.